Literature DB >> 6982311

Defective production of interferon-alpha associated with HLA-DW2 antigen in stable multiple sclerosis.

R Salonen, J Ilonen, M Reunanen, A Salmi.   

Abstract

Interferon (IFN) production by peripheral blood mononuclear cells after induction with one purified and three crude viral antigens was studied in 29 patients with stable multiple sclerosis (MS) and 29 healthy controls. Antiviral substance produced was characterized as interferon-alpha. MS patients produced significantly less IFN-alpha after induction with mumps and purified measles virus antigens and the same tendency was seen after induction with rubella virus antigen. However, when herpes simplex virus antigen was used as the stimulating agent, no difference was seen between MS patients and controls. The decreased ability to produce IFN-alpha was associated with the histocompatibility antigen Dw2. Control subjects positive for Dw2 also produced less IFN-alpha than Dw2-negative controls. In conclusion, we suggest that the observed impaired interferon-alpha production in MS is at least partially due to a high prevalence of Dw2 antigen in this disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982311     DOI: 10.1016/0022-510x(82)90101-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Absence of immunoreactive interferon-alpha in CSF from patients with multiple sclerosis.

Authors:  R J Abbott; P D Giles; I Bolderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

2.  Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis.

Authors:  J C Craig; S A Hawkins; M W Swallow; J A Lyttle; V H Patterson; J D Merrett; M Haire
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

3.  Influence of prostaglandin E2 and indomethacin on interferon-gamma production by cultured peripheral blood leukocytes of multiple sclerosis patients and healthy donors.

Authors:  G Vervliet; H Deckmyn; H Carton; A Billiau
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

4.  Interferon-gamma production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseases.

Authors:  G Vervliet; H Carton; A Billiau
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

5.  Interferon production by cultured peripheral leucocytes of MS patients.

Authors:  G Vervliet; H Carton; E Meulepas; A Billiau
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.